CGC2024@icgcs P.474

ICGCS Telegram 474

🔹Key Speaker of CGC2024
🔸Dr. Vahid Khoddami
Vahid Khoddami is the founder and CEO of ReNAP Therapeutics. Khoddami received his BSc in Medical laboratory sciences from Tehran University of Medical Sciences, his MSc in medical biotechnology from Tarbiat Modarres University and his PhD in Oncological Sciences from University of Utah (Cairns lab; HHMI, Department of Oncological Sciences). He then served as postdoctoral fellow for one year at the Huntsman Cancer Institute, Utah, then moved to Boston to spend three more years as postdoctoral fellow at Harvard Medical School (Moazed lab; HHMI, Department of Cell Biology). Eventually following ten years of study and research in United States, in the field of epigenomics and epitrascriptomics with emphasis on RNA modification studies, Khoddami returned to Iran in 2017, and in 2019 he founded ReNAP Therapeutics, a leading company in the field of mRNA technology in Iran and the region.

🌐 WWW.ICGCS.COM
🔺 T.me/icgcs
🔺 instagram.com/icgcs

www.tgoop.com/icgcs/474

4.0K viewsedited Sep 30, 2024 at 17:41

tgoop.com/icgcs/474

Create: 2024-09-30
Last Update: 2025-02-24 05:11:30

🔹Key Speaker of CGC2024
🔸Dr. Vahid Khoddami
Vahid Khoddami is the founder and CEO of ReNAP Therapeutics. Khoddami received his BSc in Medical laboratory sciences from Tehran University of Medical Sciences, his MSc in medical biotechnology from Tarbiat Modarres University and his PhD in Oncological Sciences from University of Utah (Cairns lab; HHMI, Department of Oncological Sciences). He then served as postdoctoral fellow for one year at the Huntsman Cancer Institute, Utah, then moved to Boston to spend three more years as postdoctoral fellow at Harvard Medical School (Moazed lab; HHMI, Department of Cell Biology). Eventually following ten years of study and research in United States, in the field of epigenomics and epitrascriptomics with emphasis on RNA modification studies, Khoddami returned to Iran in 2017, and in 2019 he founded ReNAP Therapeutics, a leading company in the field of mRNA technology in Iran and the region.

🌐 WWW.ICGCS.COM
🔺 T.me/icgcs
🔺 instagram.com/icgcs

BY CGC2024

Share with your friend now:
tgoop.com/icgcs/474

Open in Telegram

Telegram News

Date: 2025-02-24|

Today, we will address Telegram channels and how to use them for maximum benefit. Step-by-step tutorial on desktop: “[The defendant] could not shift his criminal liability,” Hui said. fire bomb molotov November 18 Dylan Hollingsworth yau ma tei The creator of the channel becomes its administrator by default. If you need help managing your channel, you can add more administrators from your subscriber base. You can provide each admin with limited or full rights to manage the channel. For example, you can allow an administrator to publish and edit content while withholding the right to add new subscribers.
from us

Telegram CGC2024
FROM American